In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
1989 • 2,060 citations
Expression of Multidrug Resistance Gene in Human Cancers
1989 • 1,305 citations
PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS
1972 • 1,130 citations
The cell biology of multiple drug resistance
1987 • 340 citations
In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
1978 • 135 citations
Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin
1986 • 119 citations
Multidrug Resistance: Molecular Biology Clinical Relevance
1989 • 114 citations
The multidrug resistance phenotype
1988 • 92 citations
Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin.
1987 • 77 citations
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance
1990 • 58 citations
Multidrug resistance and its circumvention
1990 • 54 citations
MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
1988 • 50 citations
Novel anthracycline analogs
1990 • 41 citations
Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.
1986 • 30 citations
Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell lines.
1991 • 29 citations
Activity of adriamycin (NSC-123127) and daunomycin (NSC-82151) against mouse mammary carcinoma.
1972 • 24 citations
Effect of MX2, a new morpholino anthracycline, against experimental brain tumors.
1990 • 12 citations